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Introduction
Lyme disease is a zoonosis caused by Spirochetes of the 
Borrelia species and transmitted to humans by lxodes ticks 
(1). While the incidence is reported to be about 30.000 per 
year in America, it is rare in our country and its incidence is 
not precisely known. The first Lyme cases in our country 
began to be reported after 1990, and vector tick species 
were identified (2-4). A high incidence is reported in the 5-10 
age group and it doubles up in adolescents and adults. The 
incidence rate due to the transmission via ticks increases 
during the spring season.
Lyme disease is a condition that can be seen in various 
parts of the body including the skin, heart and the central 
nervous system (CNS). Clinical manifestations are grouped in 
two stages as early and late. The most important finding of 
the early stage is erythema migrans. The late stage findings 
are observed months later in the patients that have not 
been treated properly. While the most common finding in 
this stage is arthritis, CNS involvement is also observed (2). 
Although Lyme disease is a rare cause of facial paralysis in 
children, it can also emerge as the only finding of the disease 
(2,5). In this report, we present a 10-year-old male case 
with complaints of extensive mouth sores, oral ulcerations, 
skin rashes and blurry vision, who was admitted to our 
department and diagnosed with isolated facial paralysis and 
Lyme disease. 
ABS TRACT Öz
Lyme disease is a zoonosis caused by Spirochetes called Borrelia burgdorferi, 
involving several areas, such as the skin, heart and central nervous system. 
In this case report, we present a 10-year-old male who had complaints of 
fever, extensive oral aphthae, perioral dried sores, rash, blurred vision and 
peripheral facial paralysis, and was diagnosed with Lyme disease. In this 
report, we want to emphasize that Lyme disease should be kept in mind for 
differential diagnosis in patients with fever and peripheral facial paralysis.
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Lyme hastalığı, Borrelia burgdorferi isimli Spiroket’in neden olduğu, deri, 
eklemler, kalp ve santral sinir sistemi gibi çok sayıda sistemi tutan bir 
zoonozdur. Bu olgu sunumunda; ateş, yaygın oral aft, peroral kurutlu yaralar, 
döküntü ve görmede bulanıklık yakınmaları ile getirilen ve periferik fasiyal 
paralizi saptanarak, Lyme hastalığı tanısı koyulan 10 yaşında bir erkek olgu 
sunuldu. Ateş ve periferik fasiyal paralizi ile başvuran hastalarda ayırıcı tanıda 
Lyme hastalığının da akılda tutulması gerektiği vurgulanmak istendi.
Anahtar Kelimeler: Fasiyal paralizi, Lyme hastalığı, Borrelia burgdorferi
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Case Report
A 10-year-old male case was referred to our hospital 
presenting with fever, extensive sores in and around the 
mouth, rashes and blurry vision. A 14-day history of the 
patient revealed that he had received a two-day irregular 
treatment with amoxicillin-clavulanate for fever, fatique and 
sore throat. Consent form was filled out by the family of the 
patient. The patient had been hospitalized because they were 
unable to bring down his temperature; and he had developed 
oral ulcerations, vesicular skin rashes around the mouth and 
face. So, he was referred to our department being unable 
to feed orally, and blurry vision although he was still under 
treatment. There was no history of staying in the countryside 
and being in contact with animals except for going on a 
picnic 15 days prior to the complaints. The patient was a 
thalassemia carrier and no characteristics were detected in 
the pedigree.
Physical examination revealed that his weight and height 
were 41 kg (75-90 p) and 147 cm (90-97 p) respectively. 
Armpit body temperature was 38.4 °C, respiratory rate 
and heart rate were 18/min and 102/min respectively, and 
his blood pressure was 106/74 mmHg. There were dried 
lesions around the mouth and on the lips, extensive major 
oral ulcerations and several gutta-sized central squamous 
papular rashes (Figure 1). Respiratory and cardiovascular 
system examinations were normal and the liver could be 
palpated 1 cm below the level. Neurological examinations 
showed disappearance of nasolabial sulcus on the left side, 
ptosis on the left corner of the mouth and right shift of 
the corner of the mouth, and that the patient was unable 
to completely close his left eye. Fundoscopic examination 
and the examination of other cranial nerves were normal. 
Strength of the leg and arm muscles were also normal, and 
deep tendon reflexes were normoactive.
Laboratory analyses showed that his hemoglobin level 
was 11.8 g/dL, hematocrit level was 36%, and the leukocyte 
and thrombocyte numbers were 6930/mm3 and 305.000/
mm3 respectively. Left shift in peripheral smear (74% 
polymorphonuclear leucocyte) was detected. Erythrocyte 
sedimentation rate was 55 mm/h, and CRP was 14.9 mg/
dL (N: 0-0.5 mg/dL). His liver and kidney functions as well 
as serum electrolytes were within optimal range. Also, the 
following results were detected: rubella immunoglobulin (Ig) 
M (-), IgG (+), toxoplasma, cytomegalovirus, herpesvirus, 
hepatitis A and B, Epstein-Barr virus IgM (-) and IgG (+); and 
Borrelia IgM was detected as positive by ELISA method. 
No active factor was isolated by multiplex polymerase 
chain reaction panel for respiratory pathway. Western Blot 
experiment to confirm the positivity of Borrelia burgdorferi 
verified the positivity on four bands. Cerebrospinal fluid (CSF), 
glucose, protein and microscopic analyses were normal, and 
antibody detection was negative. Throat, blood, urine and CSF 
cultures did not show any growth. Electrocardiography (ECG), 
echocardiography (Echo) and cranial magnetic resonance 
imaging examinations were all within normal range. 
Detailed full body examination of the patient did not 
reveal any evidence of the presence of ticks or tick bites. 
Ceftriaxone treatment (75 mg/kg/day) was started. On the 
second day, the patient’s fever was brought down, and facial 
nerve sensory and motor functions were completely normal 
in the second week. Oral ulcerations and wounds around 
the mouth were healed. The treatment was completed and 
he was discharged in the third week; and during periodical 
examinations, no complications were observed in the patient.
Discussion
Lyme disease is transmitted to humans by the Spirochete 
species “Borrelia burgdorferi”. The initial cause was isolated 
by Willy Burgdorfer in 1982 from the tick species Ixodes 
dammini, which is found on the North American deer (6). The 
prevalence of Borrelia burgdorferi in our country is unclear, 
but the incidence has been increasing. Most of the literature 
published are case studies that include reports of adults living 
in the countryside. In our country, seropositivity is 6-44% in 
the risk groups, whereas it is 2-6% in normal populations, and 
varies depending on the region (7).
Clinical manifestations are divided into two phases as 
early and late. The early stage is grouped as localized and 
disseminated. The skin lesions called eritema migrans, are 
swollen, sharp and restricted, pale in the middle and bright 
red on the outer edge. They are typical in the early localized 
stage, and are seen in 50-60% of the cases. Nonspecific 
systemic symptoms such as fever, headache, lethargy and 
myalgia are also findings observed in this stage. On the other 
hand, early disseminated stage is seen in 20% of the cases. 
The clinical findings specific for this stage are plaque or 
nodule-like multiple skin lesions that are smaller than eritema 
migrans and farther than the location of the tick bite, carditis, 
aseptic meningitis, facial paralysis, peripheric neuropathy 
transverse myelitis may be monitored. Prevalence of the 
neurological symptoms is higher in children. Late stage is 
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Figure 1. Widespread lesions on the mouth and on the lips, several 
rashes of maculopapules on the face
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observed months later in untreated cases. In this stage, 
primarily CNS involvement together with findings such 
as arthritis in large joints and encephalitis are observed 
(2). Findings of fatique, fever, extensive mouth sores and 
dried skin lesions, the presence of multiple squamous 
papular rashes different from eritema migrans, and unilateral 
facial paralysis led us to think of early disseminated stage. 
However, the ECG and Echo were normal. Possible findings 
of myocarditis and cardiac involvement with atrioventricular 
blocks were not observed in our patient.
Facial paralysis is seen in 11% of the Lyme disease 
cases, and in 30-40% of the cases facial paralysis is reported 
as bilateral (8). It can emerge within few days of, or three 
weeks after the disease onset, and the prognosis is generally 
good (9). A study conducted by Clark et al. (10) reported 
that 99.2% of the facial paralysis related to Lyme disease 
spontaneously recovers. A case report from our country too 
reported that a patient completely recovered at the end of 
the first month (11). Our patient also developed acute facial 
paralysis in the second week, and on the fourth day of the 
treatment full response was obtained and the facial paralysis 
was fully recovered.
For diagnosis, the antibody detection is conducted 
by ELISA or Immunofluorescence Antibody test. In the 
second step of diagnosis, confirmation with Western Blot 
is suggested (4). However, a study conducted in Canada 
reported that the positivity of nine out of 40 patients (22.5%) 
was detected by one or more ELISA tests, while Western 
Blot test gave negative results (12).
Oral doxycycline or amoxicillin is used for treatment 
during the early stage. On the other hand, in the case of 
neuroborreliosis and serious heart involvement, parenteral 
ceftriaxone treatment for 14-21 days is necessary (2). A 
complete remission is obtained in 80% of the cases with 
antibiotic treatment when facial neuropathy is present. 
Although spontaneous recovery is possible for isolated cranial 
neuropathies, the prevention of neurological complications 
is targeted by treatment with antibiotics. Because of 
the irregular use of amoxicillin, and the lumbar puncture 
procedure in order to eliminate the possible CNS involvement 
upon neurological findings, as well as the difficulties in oral 
intake due to the extensive oral wounds, the patient was 
treated with the appropriate dose of parenteral ceftriaxone. 
No complications have emerged in the patient who fully 
responded to the treatment.
In conclusion, Lyme disease is a rare infectious agent 
seen and detected as an etiological cause in the cases with 
facial neuropathy. However, the diagnosis of Lyme disease in 
our patient, who is neither living in the countryside nor has 
contact with animals, might be an indicator of the spreading 
of the disease, and the increase in the agent tick species 
in our country. Therefore, differential diagnosis should be 
considered and serum antibodies should be investigated 
in such cases. Early diagnosis and treatment at the onset 
of the disease will help control the symptoms and prevent 
neurological complications.
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